From Protocol to Practice: EuroIntervention’s Role in ESC Hot Line 7
Davide Capodanno, Professor of Cardiology at University of Catania, Italy has posted on X:
“To all enthusiasts of platelets, hemostasis, and thrombosis: ESC Hot Line Session 7, focused on antiplatelet therapy in ACS/PCI, is notable for the coincidental fact that all featured trials had their protocol designs published in EuroIntervention. This is gratifying, as it reflects both the trust of leading investigators and the effectiveness of our radar at an early stage.
NEO-MINDSET – Early aspirin withdrawal after PCI for ACS: read more here.
TAILORED-CHIP – Personalized antiplatelet therapy in complex high-risk PCI: read more here.
TARGET-FIRST – Early aspirin discontinuation post-PCI in acute MI: read more here.
DAPT-SHOCK-AMI – Cangrelor in cardiogenic shock: read more here.”
Explore more on Hemostasis Today.
-
Jun 8, 2026, 17:50From Bleeding to Swelling – A Shared Therapeutic Revolution in Rare Diseases – RPTH Journal
-
Jun 8, 2026, 17:36Sophia Delicou: Decoding Acute Pain Transfusion Reactions in Thalassemia
-
Jun 8, 2026, 16:21Ifeanyichukwu Ifechidere: Reflections on the UK NEQAS Coagulation and Haemostasis Conference
-
Jun 8, 2026, 16:00Despina Fotiou: Advancing Recognition Through Global Case Collaboration
-
Jun 8, 2026, 15:43Jigyasa Pal: Beyond Care – Empowering Lives with HPAP
-
Jun 8, 2026, 15:36New Approaches in Bleeding Disorders Care – SAHF
-
Jun 8, 2026, 15:34Besher Shami: A Unique Presentation of Warfarin-Associated Aortic Perforation
-
Jun 8, 2026, 15:29Shreyashree Sarkar: Oxidative Stress and Neutrophil-Driven Mechanisms in Cancer-Associated Thrombosis at Vascular Discovery 2026
-
Jun 8, 2026, 15:23Gloria Duah: Can a Blood Transfusion Change Your Blood Type?